Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
Cocaine-Induced Microvascular Dysfunction and its Reversal by Administration of Intracoronary Calcium-Channel Blocker
Bhalaghuru Chokkalingam Mani, David L Fischman, Michael P Savage1
1Cardiac Catheterization Laboratory, Thomas Jefferson University Hospital. Gibbon Bldg., Ste 6210, 111 S. 11th Street, Philadelphia, PA 19107 USA. michael.savage@jefferson.edu.
Insights
This case study highlights a novel treatment for cocaine-induced chest pain. An intracoronary calcium-channel blocker effectively treated microvascular spasm in a patient unresponsive to nitroglycerin.
Area of Science:
- Cardiology
- Pharmacology
- Toxicology
Background:
- Cocaine use is associated with cardiovascular complications, including myocardial infarction and vasospasm.
- Chest pain is a common presentation in patients with cocaine-induced cardiovascular events.
- Standard treatments like nitroglycerin may be ineffective in severe cases.
Observation:
- A 47-year-old male smoker with recent cocaine use presented with persistent chest pain.
- The patient's chest pain was refractory to both sublingual and intravenous nitroglycerin.
- This refractory presentation suggested a microvascular etiology, possibly related to cocaine's sympathomimetic effects.
Findings:
- The study reports the first successful use of an intracoronary calcium-channel blocker to manage cocaine-induced microvascular spasm.
- Administration of the calcium-channel blocker resulted in rapid amelioration of chest pain and likely restored coronary blood flow.
- This intervention targeted the specific mechanism of cocaine-induced coronary microvascular dysfunction.
Implications:
- Intracoronary calcium-channel blockers represent a potential therapeutic option for refractory cocaine-induced coronary vasospasm.
- This approach may be particularly useful in patients who do not respond to conventional therapies.
- Further research is warranted to establish the safety and efficacy of this treatment strategy in a larger cohort.
Abstract:
A 47-year-old male smoker with recent cocaine use presented with 6 hours of chest pain unrelieved by sublingual and intravenous nitroglycerin. To our knowledge, this is the first reported case demonstrating the efficacy of an intracoronary calcium-channel blocker to ameliorate cocaine-induced microvascular spasm.
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease V: Interprofessional Care
Antihypertensive Drugs: Action of Calcium Channel Blockers
Acute Coronary Syndrome IV: Interprofessional Care
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Coronary Artery Disease II: Pathophysiology

